• <bdo id="d74tz"><strong id="d74tz"></strong></bdo>

    <style id="d74tz"></style>

        <ruby id="d74tz"></ruby>

      • 国产无套乱子伦精彩是白视频,亚洲欧美激情精品一区二区,好大好硬好深好爽想要20p,亚洲综合一区二区三区在线,国产一区二区三区啪,久久国产综合精品欧美,欧美成人怡红院一区二区,午夜日本永久乱码免费播放片
        咨詢熱線

        15000266580

        當前位置:首頁 >產品中心>細胞庫>人腫瘤細胞、癌細胞>CRL-2557Panc 05.04 人胰腺癌細胞

        Panc 05.04 人胰腺癌細胞

        簡要描述:CRL-2557 Panc 05.04 人胰腺癌細胞,
        原代細胞|細胞系|細胞株|菌種;細胞庫管理規范,
        提供的細胞株背景清楚,提供參考文獻和培養條件!

        • 產品型號:CRL-2557
        • 廠商性質:生產廠家
        • 更新時間:2025-09-11
        • 訪  問  量:2329

        產品分類

        Product Category

        詳細介紹

        CRL-2557 Panc 05.04 人胰腺癌細胞

        ATCC® Number: CRL-2557™ Price: $417.00

        Designations: Panc 05.04

        Depositors: EM Jaffee

        Biosafety Level: 1

        Shipped: frozen

        Medium & Serum: See Propagation

        Growth Properties: adherent

        Organism: Homo sapiens (human)

        Morphology: epithelial

        Source: Organ: pancreas

        Disease: adenocarcinoma

        Cellular Products: cytokeratins 7 and 18 [50655]

        Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimay responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.


        CRL-2557 Panc 05.04 人胰腺癌細胞

        Isolation: Isolation date: May 5, 1995

        Tumorigenic: Yes

        Oncogene: K-ras +

        Antigen Expression: MHC class I +; MHC class II - [50655]

        Blood type B; Rh+

        Age: 77 years adult

        Gender: female

        Ethnicity: White

        Comments: Panc 05.04 is a pancreatic adenocarcinoma epithelial cell line derived, in 1995, from a primary tumor removed from the head-of-the-pancreas of a female with pancreatic adenocarcinoma.

        The cell line exhibits a K-ras oncogene mutation at codon 12 where a GGT --> GAT mutation resulted in substitution of aspartic acid for glycine. [50655]

        The cells have a reported plating efficiency of 100%. [50655]

        Propagation: ATCC complete growth medium: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate and supplemented with 20 Units/ml human recombinant insulin, 85%; fetal bovine serum, 15%

        Atmosphere: air, 95%; carbon dioxide (CO2), 5%

        Temperature: 37.0°C

        Subculturing: Protocol:

        1.Remove and discard culture medium.

        2.Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.

        3.Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).

        Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

        4.Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.

        5.To remove trypsin-EDTA solution, transfer cell suspension to centrifuge tube and spin at approximay 125 xg for 5 to 10 minutes.Discard supernatant and resuspend cells in fresh growth medium. Add appropriate aliquots of cell suspension to new culture vessels.

        6.Incubate cultures at 37°C.

        Subc*tion Ratio: A subc*tion ratio of 1:3 to 1:5 is recommended

        Medium Renewal: Add media once per week. Fluid change one to two times per week.

        Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO

        Storage temperature: liquid nitrogen vapor phase

        Doubling Time: 46 hrs

        Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001

        recommended serum:ATCC 30-2020

        References: 50655: Jaffee EM, et al. Development and characterization of a cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials. Cancer J. Sci. Am. 4: 194-203, 1998. PubMed: 9612602

        CRL-2557


















        產品咨詢

        留言框

        • 產品:

        • 您的單位:

        • 您的姓名:

        • 聯系電話:

        • 常用郵箱:

        • 省份:

        • 詳細地址:

        • 補充說明:

        • 驗證碼:

          請輸入計算結果(填寫阿拉伯數字),如:三加四=7
        聯系方式

        郵箱:xiangfbio@163.com

        地址:上海市虹口區四平路710號7層

        咨詢熱線

        400-821-8510

        (周一至周日9:00- 19:00)

        在線咨詢
        • 掃一掃 微信咨詢

        Copyright©2025 上海復祥生物科技有限公司 All Right Reserved    備案號:滬ICP備10013034號-2     sitemap.xml
        技術支持:化工儀器網    管理登陸
        主站蜘蛛池模板: 中文字幕日韩精品亚洲一区| av色国产色拍| 成全影视大全在线观看| 久久93精品国产91久久综合| 乱色熟女综合一区二区三区| 亚洲美女av一区二区| 国产真实伦在线观看视频| 亚洲欧美人成人让影院| 精品无码国产污污污免费| 国产成人精品午夜在线观看| 国产成人综合网在线观看| 韩国午夜理论在线观看| 久久精品女人的天堂av| 一本一道中文字幕无码东京热| 1精品啪国产在线观看免费牛牛| 亚洲精品日韩精品久久| 久久99九九精品久久久久蜜桃 | 中文字幕乱码十国产乱码| 伊人久久精品无码麻豆一区| 亚洲国产视频精品一区二区| 在线精品亚洲区一区二区| 中文字幕人成乱码中文乱码 | 国产亚洲精品自在久久vr| 精品欧美一区二区三区久久久| 国产超碰无码最新上传| 国产日韩久久免费影院| 亚洲精品成人网线在线播放va| 亚洲综合网站久久久| 亚洲精品久久久久国色天香| 久久精品视频一二三四区| 内射一区二区三区四区| 97人人添人人澡人人澡人人澡| 人人超碰人摸人爱| 日本一区二区三本视频在线观看| 久久久久国产一级毛片高清版A| 久久精品国产亚洲av麻豆长发| 久久久国产成人一区二区| 久久国产精品不只是精品| 亚洲第一国产综合| 2020久久国产综合精品swag| 亚洲av成人无码天堂|